{"task_id": "d8a9d7bc546a56b6", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 862/905)", "text": "dated 2013. https://www.\nnice.org.uk/guidance/cg94\n\n--- Page 868 ---\n854\nReferences\n9 Nattel S, Opie LH. Controversies in atrial \ufb01 brillation. Lancet 2006; 367:262. http://www.thelancet.com/\njournals/lancet/article/PIIS0140-6736(06)68037-9/abstract\n10 Behr ER, Veysey MJ, Berry D, et al. Optimum dose of digoxin. Lancet 1997; 349(9068):1845 http://www.\nthelancet.com/journals/lancet/article/PIIS0140-6736(05)61735-7/fulltext\n11 The Digitalis Investigation Group. The eff ect of digoxin on mortality and morbidity in patients with \nheart failure. N Engl J Med 1997; 336:525\u201333. http://www.nejm.org/doi/full/10.1056/NEJM199702203360801\n12 NICE. General principles for treating people with stable angina. In Stable angina: Management [CG126], \nChapter 1.3. 2011, updated 2016. https://www.nice.org.uk/guidance/cg126/chapter/1-Guidance#general-\nprinciples-for-treating-people-with-stable-angina\n13 NICE. Chest pain of recent onset: Assessment and diagnosis [CG95]. 2010, updated 2016. http://www.\nnice.org.uk/guidance/CG95\n14 Roffi   M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syn-\ndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2016; 37(3):267\u2013315. \nhttp://eurheartj.oxfordjournals.org/content/37/3/267.long\n15 Task Force on the management of ST-segment elevation acute myocardial infarction of the European \nSociety of Cardiology (ESC). ESC Guidelines for the management of acute myocardial infarction in patients \npresenting with ST-segment elevation. Eur Heart J 2012; 33(20):2569\u2013619. http://eurheartj.oxfordjournals.\norg/content/33/20/2569.long\n16 Junghans C. Risk assessment after acute coronary syndrome. BMJ 2006; 333:1080. http://www.bmj.\ncom/content/333/7578/1079\n17 Lichtman JH, Bigger JT, Blumenthal JA, et al. Depression and Coronary Heart Disease: Recommenda-\ntions for Screening, Referral, and Treatment: A Science Advisory From the American Heart Association \nPrevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council \non Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: \nEndorsed by the American Psychiatric Association. Circulation 2008; 118:1768\u201375. http://circ.ahajournals.\norg/content/118/17/1768.long\n18 DVLA. Cardiovascular disorders: Assessing \ufb01 tness to drive. March 2016. https://www.gov.uk/guid-\nance/cardiovascular-disorders-assessing-\ufb01 tness-to-drive\n19 Gorenek B, Lundqvist C, Terradellas J, et al. Cardiac arrhythmias in acute coronary syndromes: position \npaper from the joint EHRA, ACCA, and EAPCI task force. Eur Heart J Acute Cardiovasc Care 2015; 4(4):386\n20 Matteson EL, Kluge FJ. Think clearly, be sincere, act calmly: Adolf Kussmaul (February 22, 1822-May 28, \n1902) and his relevance to medicine in the 21st century. Curr Opin Rheumatol 2003; 15(1):29\u201334\n21 Massimo M. Minimally invasive coronary surgery: fad or future? BMJ 1998; 316:88\n22 NICE. Off-pump coronary artery bypass grafting [IPG377]. 2011. http://guidance.nice.org.uk/IPG377\n23 Brown WR, Moody DM, Venkata R, Challa VR, et al. Longer duration of cardiopulmonary bypass is as-\nsociated with greater numbers of cerebral microemboli. Stroke 2000; 31 707\u201313. http://stroke.ahajournals.\norg/content/31/3/707\n24 Perez-Silva A, Merino J. Frequent ventricular extrasystoles: signi\ufb01 cance, prognosis and treatment. \nESC E-J Cardiol Pract 2011; 9(17). http://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/\nVolume-9/Frequent-ventricular-extrasystoles-signi\ufb01 cance-prognosis-and-treatment\n25 NICE. Atrial \ufb01 brillation: Management. 2014. https://www.nice.org.uk/guidance/cg180/chapter/1-\nRecommendations\n26 Lubitz SA, Magnani JW, Ellinor PT, et al. Atrial \ufb01 brillation and death after myocardial infarction: risk \nmarker or causal mediator? Circulation 2011; 123:2063\u20135. http://circ.ahajournals.org/content/123/19/2094.\nabstract\n27 Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with \natrial \ufb01 brillation. N Engl J Med 2002; 347:1825\u201333. http://www.nejm.org/doi/full/10.1056/NEJMoa021328\n28 Oral H. Circumferential pulmonary-vein ablation for chronic atrial \ufb01 brillation. N Engl J Med 2006; \n354(9):934\u201341. http://www.nejm.org/doi/full/10.1056/NEJMoa050955\n29 Phang R, Prutkin J, Ganz L. Overview of atrial \ufb02 utter. UpToDate\u00ae. 2015. http://www.uptodate.com/\ncontents/overview-of-atrial-\ufb02 utter?source=search_result&search=atrial+\ufb02 utter&selectedTit le=1~150\n30 Mant J. Warfarin vs aspirin for stroke prevention in elderly with atrial \ufb01 brillation (the Birmingham \nAtrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; \n370:493\u2013503. http://www.thelancet.com/journals/lancet/article/PIIS0140673607612331/abstract\n31 Bristow M, Saxon L, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable \nde\ufb01 brillator in advanced chronic heart failure. N Engl J Med 2004; 350(21):2140\u201350. http://www.nejm.org/\ndoi/full/10.1056/NEJMoa032423 \n32 NICE. Implantable cardioverter de\ufb01 brillators and cardiac resynchronisation therapy for arrhyth-\nmias and heart failure [TA314]. 2014. https://www.nice.org.uk/guidance/ta314\n33 NICE. Chronic heart failure [CG108]. 2010. https://www.nice.org.uk/guidance/cg108\n34 Patient. Palliative care of heart failure. 2016. http://www.patient.co.uk/showdoc/40024526/\n35 McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framing-\nham study. N Engl J Med 1971; 285(26):1441\u20136. http://www.nejm.org/doi/full/10.1056/NEJM197112232852601\n36 Dargie HJ, McMurray JJ. Diagnosis and management of heart failure. BMJ 1994; 308:321\u20138. https://\nwww.ncbi.nlm.nih.gov/pmc/articles/PMC2539274/\n37 Levenson JW, McCarthy EP, Lynn J, et al. The last six months of life for patients with congestive heart fail-\nure. J Am Geriatr Soc 2000; 48(5 Suppl):S101\u20139. http://onlinelibrary.wiley.com/doi/10.1111/j.1532-5415.2000.\ntb03119.x/abstract\n38 Cleland JG, McGowan J, Clark A, et al. The evidence for beta blockers in heart failure. BMJ 1999; 318:824\u2013\n5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1115260/\n39 Fonarow GC, Abraham WT, Albert NM, et al. In\ufb02 uence of beta-blocker continuation or withdrawal on \noutcomes in patients hospitalized with heart failure: \ufb01 ndings from the OPTIMIZE-HF program. J Am Coll \nCardiol 2008; 52(3):190\u20139\n40 Pitt B, Zannad F, Remme WJ, et al. The eff ect of spironolactone on morbidity and mortality in patients \nwith severe heart failure. N Engl J Med 1999; 341:709\u201317. http://content.nejm.org/cgi/reprint/341/10/709.pdf \n41 Taylor AL, Ziesche S, Yancy C, et al. Combination of isosorbide dinitrate and hydralazine in blacks with \nheart failure. N Engl J Med 2004; 351(20):2049\u201357. http://content.nejm.org/cgi/content/full/351/20/2049", "text_length": 6817, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 862/905)", "type": "chunk", "chunk_index": 861, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:53.671638", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:53.672326", "status": "complete", "chunks_added": 4}